Diabetes Clinical Trials in Portland

Showing 41-60 of 404 trials

Assess the Efficacy and Safety of Repeat Intravitreal Injections of Foselutoclax (UBX1325) in Patients With DME (ASPIRE)

NCT06011798

The goal of this clinical trial is to assess the efficacy and safety of multiple doses of foselutoclax (UBX1325) in patients with Diabetic Macular Edema. The main questions the study aims to answer are: * Assess the efficacy of foselutoclax compared to aflibercept * Assess the safety and tolerability of foselutoclax

Diabetic Macular EdemaRetinal DiseaseMacular Edema+6 more

Unity Biotechnology, Inc.52 participantsStarted Aug 2023

Bakersfield, California, United States • Beverly Hills, California, United States • Huntington Beach, California, United States +16 more locations

COMPLETEDNA< 1 mile

DailyDose Smart Snack Study for T1D on MDI

NCT05967260

This is a single-center, open-label, crossover trial with two arms and two periods (2x2) and one-week washout period. The study is designed to evaluate the efficacy of an AI-based bedtime smart snack intervention in reducing nocturnal low glucose in people living with T1D on MDI therapy compared with traditional CGM-augmented MDI therapy as the control.

Type 1 Diabetes Mellitus With Hypoglycemia

Oregon Health and Science University21 participantsStarted Sep 2023

Portland, Oregon, United States

Assess the Efficacy and Safety of Repeat Intravitreal Injections of Foselutoclax (UBX1325) in Patients With DME (ASPIRE)

DailyDose Smart Snack Study for T1D on MDI

Diabetes Trials in Other Cities

T1D Pregnancy & Me

Closed Loop Context Aware AID

Wearable Devices on Health Promotion in Diabetes

Evaluation of the MiniMed™ 780G System in Type 1 Adult and Pediatric Subjects Utilizing Insulin Fiasp®

A Study to Investigate the Efficacy and Safety of Canagliflozin in Children and Adolescents (>=10 to <18 Years) With Type 2 Diabetes Mellitus

Efficacy, Safety, and PK of LX9211 in Participants With Diabetic Peripheral Neuropathic Pain

A Study of Insulin Efsitora Alfa (LY3209590) Compared With Insulin Degludec in Participants With Type 1 Diabetes Treated With Multiple Daily Injection Therapy

A Study of Insulin Efsitora Alfa (LY3209590) Compared With Insulin Degludec in Participants With Type 2 Diabetes Currently Treated With Basal Insulin

HbA1c Variation Study

A Study of Insulin Efsitora Alfa (LY3209590) as a Weekly Basal Insulin Compared to Insulin Glargine in Adult Participants With Type 2 Diabetes on Multiple Daily Injections

Trial of Semaglutide for Diabetic Kidney Disease in Type 1 Diabetes

The Diabetes Prevention Program Outcomes Study AD/ADRD Project

Afrezza® INHALE-1 Study in Pediatrics

AI Ready and Exploratory Atlas for Diabetes Insights

A Study of LY3549492 in Adults With Obesity or Overweight With Type 2 Diabetes

An Efficacy, Safety, and Tolerability Study of VX-880 in Participants With Type 1 Diabetes With a Kidney Transplant

A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Semaglutide (COMBINE 2)

Safety and Effectiveness of the Luna System in People With Type 1 Diabetes Mellitus

Other Conditions in Portland